In summary, our findings reveal that c‐Myc‐i7 treatment elicits distinct alterations in cell cycle and apoptosis dynamics in breast and prostate cancer cell lines, underscoring its differential impact on these malignancies. The gene discussed is MYC; the disease is prostate cancer.